James Jesso – Rehabilitating After Bad Trips

The Australian Psychedelic Society-Sydney presents an afternoon tackling the dark side of psychedelics on Sunday October 27 in Sydney. We will be hosting an afternoon with the insighful, James W. Jesso, whilst also handing over the microphone to you, the psychedelic community, to share your own stories. “Bad trips: rehabilitating after psychedelic turmoil” Bad Trips […]

Continue reading

Esketamine Approved by the FDA for Treatment Resistant Depression

Marco Stojanovik Following a review of clinical trial results and consultation with external advisors, the Food and Drug Administration (FDA) has granted approval for Spravato to be used in patients with treatment-resistant depression in the United States. Spravato is a nasal spray produced by Janssen Pharmaceuticals Inc. that contains esketamine hydrochloride, a chemical mirror to […]

Continue reading